Insider · CIK 0002022797
Jeremy J. Heaton
cfoofficer
Files at ALIT (Alight, Inc. / Delaware). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -21,096 | $6.11 | $129k | 783,629 | Mar 17, 2025 |
| Mar 10, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -4,910 | $6.16 | $30k | 642,388 | Mar 12, 2025 |
| Mar 10, 2025 | ALIT Alight, Inc. / Delaware | AGrant or award Class A Common Stock | +162,337 | $0.00 | $0 | 804,725 | Mar 12, 2025 |
| Feb 28, 2025 | ALIT Alight, Inc. / Delaware | AGrant or award Class A Common Stock | +78,160 | $0.00 | $0 | 673,233 | Mar 4, 2025 |
| Feb 28, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -29,285 | $6.83 | $200k | 643,948 | Mar 4, 2025 |
| Feb 28, 2025 | ALIT Alight, Inc. / Delaware | AGrant or award Class A Common Stock | +4,739 | $0.00 | $0 | 648,687 | Mar 4, 2025 |
| Feb 28, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -1,389 | $6.83 | $9,487 | 647,298 | Mar 4, 2025 |
| Feb 12, 2025 | ALIT Alight, Inc. / Delaware | AGrant or award Class A Common Stock | +23,765 | $0.00 | $0 | 603,069 | Feb 14, 2025 |
| Feb 12, 2025 | ALIT Alight, Inc. / Delaware | FTax withholding Class A Common Stock | -7,996 | $6.64 | $53k | 595,073 | Feb 14, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.